Abbvie Inc risk profile
57 Elevated one input has moved against it
Measured 21 October 2026 from ABBV's filed statements. Recomputed nightly.
57 (Elevated), driven by Concentration at 73, over 6 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 17 | Contained | Stable | One-year price volatility — 25.8% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 8 | Contained | Stable | Capital spending against operating cash — 0.06x |
| Leverage and coverage | 53 | Elevated | Easing | Net debt to EBITDA — 3.50x |
| Competitive position | 59 | Elevated | Stable | Operating-margin gap against peers — -0.1 percentage points |
| Concentration | 73 | Stretched | Stable | Geographic concentration — 5,831 HHI |
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.